SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-009189
Filing Date
2023-03-22
Accepted
2023-03-22 16:20:19
Documents
6
Effectiveness Date
2023-03-22

Document Format Files

Seq Description Document Type Size
1 S-8 2023_form_s-8.htm S-8 200158
2 EX-5.1 rani-ex5_1.htm EX-5 22181
3 EX-23.2 rani-ex23_2.htm EX-23 3924
4 EX-FILING FEES rani-exfiling_fees.htm EX-FILING FEES 38414
5 GRAPHIC img244382500_0.jpg GRAPHIC 2126
6 GRAPHIC img244382500_1.jpg GRAPHIC 2126
  Complete submission text file 0000950170-23-009189.txt   271806
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270747 | Film No.: 23753199
SIC: 2834 Pharmaceutical Preparations